Antares Pharma, Inc. (ATRS) Financial Analysis & Valuation | Quarter Chart
Antares Pharma, Inc. (ATRS)
ATRSPrice: $5.59
Fair Value: 🔒
🔒score
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using it... more
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and c... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Robert Apple |
| IPO Date | 1996-10-03 | CAGR | 0.17% |
| Employees | 201 | Website | www.antarespharma.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ATRS chart loading...
Fundamentals
Technicals
| Enterprise Value | $661.20M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 5.41 |
| P/CF Ratio | 25.97 | P/FCF Ratio | — |
| EPS | $0.37 | EPS Growth 1Y | -32.53% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 15.67% | Gross Margin | 0.63% |
| Operating Margin | 0.34% | Profit Margin | 0.25% |
| ROE | 0.31% | ROA | 0.18% |
| ROCE | 0.31% | Current Ratio | 2.74 |
| Quick Ratio | 2.55 | Cash Ratio | 1.12 |
| Debt/Equity | 0.14 | Interest Coverage | — |
| Altman Z Score | — | Piotroski Score | — |